HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)
China · Delayed Price · Currency is CNY 2.720
+0.010 (0.37%)
Jun 9, 2026, 3:04 PM CST
SHE:002437 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 411.58 | 376.91 | 232.76 | 120.33 | -291.33 | 45.04 |
Depreciation & Amortization | 90.24 | 90.24 | 91.96 | 104.38 | 130.05 | 144.5 |
Other Amortization | 0.55 | 0.55 | - | 5.19 | 5.66 | 5.66 |
Loss (Gain) From Sale of Assets | -3.54 | -3.54 | -3.4 | -2.84 | -3.82 | -4.65 |
Asset Writedown & Restructuring Costs | 8.88 | 8.88 | 3.53 | 0.28 | 79.45 | 1.84 |
Loss (Gain) From Sale of Investments | -142.5 | -142.5 | 8.73 | 41.37 | 269.57 | 9.31 |
Provision & Write-off of Bad Debts | 0.1 | 0.1 | -0.4 | -0.21 | -0.31 | -0.53 |
Other Operating Activities | -56.88 | 11.56 | 18.93 | 58.95 | 97.17 | 96.45 |
Change in Accounts Receivable | -6.63 | -6.63 | 77.65 | 63.57 | 55.14 | 133.55 |
Change in Inventory | -19.22 | -19.22 | -31.04 | 35.44 | 120.41 | 22.09 |
Change in Accounts Payable | -50.33 | -50.33 | -17.05 | -97.86 | -191.09 | -183.67 |
Change in Other Net Operating Assets | 7.5 | 7.5 | 23.56 | -66.44 | - | - |
Operating Cash Flow | 239.59 | 273.36 | 410.94 | 274.18 | 261.62 | 274.18 |
Operating Cash Flow Growth | -33.11% | -33.48% | 49.88% | 4.80% | -4.58% | 2048.11% |
Capital Expenditures | -21.59 | -23.81 | -62.9 | -29.62 | -33.01 | -34.51 |
Sale of Property, Plant & Equipment | 29.02 | 11.42 | 18.73 | 13.65 | 40.05 | 3.04 |
Cash Acquisitions | -0.3 | -0.3 | -2.66 | - | - | - |
Divestitures | - | - | - | 0.73 | 2.88 | 74.92 |
Investment in Securities | -2.47 | -361.14 | -24 | 103.01 | -250 | 31.66 |
Other Investing Activities | 44.29 | 41.48 | 11.97 | 6.61 | 16.2 | 6.15 |
Investing Cash Flow | 48.95 | -332.35 | -58.86 | 94.38 | -223.88 | 81.26 |
Short-Term Debt Issued | - | 90 | 115 | 1,095 | 1,556 | 1,948 |
Total Debt Issued | 20 | 90 | 115 | 1,095 | 1,556 | 1,948 |
Short-Term Debt Repaid | - | - | -789.86 | -1,873 | - | -1,672 |
Long-Term Debt Repaid | - | -1.5 | -1.05 | - | -1,659 | - |
Total Debt Repaid | -71.5 | -1.5 | -790.91 | -1,873 | -1,659 | -1,672 |
Net Debt Issued (Repaid) | -51.5 | 88.5 | -675.91 | -778.13 | -103.02 | 275.42 |
Issuance of Common Stock | - | - | 103.21 | - | - | - |
Repurchase of Common Stock | -99.72 | -99.72 | -1.19 | - | - | - |
Common Dividends Paid | -1.48 | -1.21 | -9.36 | -43.81 | -68.76 | -70.94 |
Other Financing Activities | 67.71 | -11.62 | - | -67.22 | -40.77 | 157.11 |
Financing Cash Flow | -84.99 | -24.05 | -583.24 | -889.16 | -212.55 | 361.59 |
Foreign Exchange Rate Adjustments | -3.23 | -1.89 | 0.94 | 0.99 | 11.92 | -1.57 |
Net Cash Flow | 200.32 | -84.94 | -230.23 | -519.62 | -162.89 | 715.46 |
Free Cash Flow | 218.01 | 249.54 | 348.04 | 244.55 | 228.6 | 239.67 |
Free Cash Flow Growth | -27.78% | -28.30% | 42.32% | 6.98% | -4.62% | - |
Free Cash Flow Margin | 10.27% | 11.69% | 14.26% | 9.31% | 7.36% | 7.62% |
Free Cash Flow Per Share | 0.10 | 0.11 | 0.15 | 0.11 | 0.10 | 0.11 |
Cash Income Tax Paid | 235.05 | 240.47 | 255.47 | 265.66 | 287.58 | 280.55 |
Levered Free Cash Flow | 38.2 | 78.31 | 351.49 | 99.6 | 51.24 | 260.36 |
Unlevered Free Cash Flow | 40.24 | 79.86 | 357.63 | 126.26 | 94.16 | 305.04 |
Change in Working Capital | -68.84 | -68.84 | 58.83 | -53.28 | -24.8 | -23.44 |